Form 4: Aethlon Medical Director Nicolas Gikakis Forfeits Shares to Cover Tax Withholdings

Director Nicolas Gikakis forfeited 3,289 shares of Aethlon Medical common stock to cover tax obligations upon the conversion of restricted stock units.

Summary

• On March 31, 2025, Nicolas Gikakis, a director of Aethlon Medical Inc., forfeited 3,289 shares of common stock.
• The forfeiture was to cover tax withholdings related to the conversion of 8,224 vested restricted stock units into common stock.
• The shares were forfeited at a price of $0.358 per share.
• Following the transaction, Gikakis directly owns 31,463 shares of Aethlon Medical Inc.
• The restricted stock units were part of a grant previously reported on April 17, 2023.

Sentiment

Score: 5

Explanation: This is a neutral event related to standard compensation practices. It doesn't indicate positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It doesn't necessarily reflect a change in the company's overall prospects or strategy.

Stakeholder Impact

• The forfeiture of shares has a negligible impact on shareholders as it is a standard procedure for covering tax obligations related to executive compensation.

Key Dates

Keywords

Aethlon Medical, Nicolas Gikakis, Form 4, Share Forfeiture, Restricted Stock Units, Tax Withholdings, Director, AEMD